WHO extends global travel restrictions on Pakistan for 3 months to counter spread of Polio
The decision was made during the 42nd meeting of the WHO Emergency Committee for Polio, held virtually on June 18. The meeting included officials from polio-affected nations and focused on the global spread of WPV1, particularly in Pakistan and Afghanistan, which were identified as ongoing international transmission risks, ARY News stated.
Islamabad: The World Health Organization (WHO) has extended conditional international travel restrictions on Pakistan for another three months, citing persistent concerns about the transmission of wild poliovirus type 1 (WPV1), ARY News reported.
According to ARY News, the WHO noted that 'the spread of WPV1 is facilitated by cross-border travel and the movement of displaced populations,' and highlighted the rise in polio-positive sewage samples across Pakistan. Sensitive areas including KP, Sindh, Balochistan, and central parts of the country remain polio hotspots, with Karachi, Peshawar, and Quetta Block serving as strongholds for the virus.
The committee also raised concerns about a new polio case reported in Gilgit-Baltistan and the growing number of children missing vaccinations, which further complicates eradication efforts.
While acknowledging that the 2025 polio eradication target is unlikely to be met under current conditions, the WHO commended Pakistan's ongoing efforts. 'The organization expressed satisfaction with Pakistan's polio eradication efforts and confidence in the quality of its vaccination campaigns,' ARY News reported.
Pakistan's Prime Minister and his team were praised for their commitment, with effective provincial and regional campaigns underway.
The WHO urged continued bilateral cooperation between Pakistan and Afghanistan to combat the virus, calling for sustained joint vaccination drives and stronger surveillance systems.
Pakistan's polio surveillance will continue for another three months, during which mandatory vaccinations will remain in place for all outbound travelers. The WHO will reassess the situation and review Pakistan's progress in polio eradication at the end of this period, according to ARY News. (ANI)
This report is auto-generated from ANI news service. ThePrint holds no responsibility for its content.
Also read: WHO warns of cross-border transmission as polio cases spike in Afghanistan, Pakistan
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
'Healthcare, education now commercialised': RSS chief Mohan Bhagwat flags accessibility crisis; says common man struggles with costs
RSS chief Mohan Bhagwat (ANI) NEW DELHI: RSS chief Mohan Bhagwat on Sunday expressed concerns over the increasing commercialisation of healthcare and education while speaking at an event in Indore. He said that both sectors, once considered acts of service, have now become unaffordable and inaccessible for the common man. 'Health and education are extremely important and were earlier considered as 'seva' (service), but now both are beyond the reach of common people. Both have been commercialised. They are neither affordable nor accessible,' Bhagwat said at an event in Indore. Citing personal experience, Bhagwat recalled, 'when I was a child, I had malaria and missed school for three days. My teacher came home, and brought jungle herbs for my treatment. He was concerned that the student who came to him should stay healthy. Society needs accessible and affordable healthcare.' Referring specifically to cancer care, he said, good cancer care is currently available in only 8-10 Indian cities, and stressed the need for healthcare that does not become a source of anxiety for patients. 'We need low-cost, easily accessible medical care. Treatment should not turn into a cause of worry,' he added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Unsold 2021 Cars Now Almost Free - Prices May Surprise You Unsold Cars | Search Ads Learn More Undo Bhagwat also said that Western medical research cannot be uniformly applied across the world due to regional and individual differences. 'Someone may benefit from naturopathy, others from homeopathy, no single way can be supreme. Indian medical systems treat based on personal needs,' he noted. On the education front, he pointed out that students still have to travel long distances for quality education, just as patients do for advanced healthcare.
Hindustan Times
7 hours ago
- Hindustan Times
‘Stratus' COVID variant spreads in US: All you need to know
A new COVID-19 variant, known as Variant XFG or "Stratus," is spreading in the United States and worldwide. Current COVID-19 vaccines are expected to continue providing protection against symptomatic and severe illness caused by this variant, according to a report by USA Today. Several countries in the South-East Asia region have reported a concurrent increase in new infections and hospital admissions where XFG is widespread. Under the WHO list of COVID variants to watch for, Nimbus has been classified as a "variant under monitoring."(Unsplash/Representational) So far, data suggest this variant does not cause more severe illness or higher mortality compared to other circulating strains. The CDC highlighted that states including Alabama, Alaska, California, Delaware, Florida, Hawaii, Kentucky, Louisiana, and Texas are experiencing high or very high case levels. Other states such as Connecticut, Georgia, Indiana, Maryland, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Utah, Virginia, Washington, and Wisconsin are also seeing a rise in cases linked to this variant. Also Read | New COVID variant bizarre symptoms: What treatments are available and how you can protect yourself All you need to know about Variant XFG XFG is a recombinant strain formed by combining two earlier variants: F.7 and LP.8.1.2, the latter now the second most common strain in the US. Scientists suggest it carries mutations that may help it evade the immune system better, though this does not mean it spreads faster. Originally identified in Southeast Asia in January, XFG accounted for nearly 0% of US cases in March but grew to 2% in April, 6% in May, and about 14% by late June, according to the Centers for Disease Control and Prevention (CDC). A similar rise has been seen globally, with the World Health Organization (WHO) reporting XFG made up 7.4% of cases in early May, increasing to 22.7% by the end of June across 38 countries. In a late June report, WHO placed XFG on its watchlist but assessed the additional public health risk as "low" worldwide. It also stated that current COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease." Classified as a SARS-CoV-2 variant under monitoring (VUM), XFG is spreading globally, but based on available evidence, WHO considers its additional public health threat to be low. What are the symptoms? The CDC continues to list common COVID symptoms such as: Fever or chills Cough Fatigue Sore throat Loss of taste or smell Congestion Muscle aches Shortness of breath Headache Nausea or vomiting
NDTV
10 hours ago
- NDTV
New COVID-19 Variant Spreading In US: All You Need To Know About XFG Variant
COVID-19 Cases In the US: The United States has lately seen an alarming rise in COVID-19 cases linked to a new variant, which has become the third-most common strain of the summer. The new XFG variant, colloquially known as "Stratus," is rapidly spreading across the US. This variant has also been found in many European countries. Variant XFG was first detected in Southeast Asia in January. According to a report by USA Today, the strain accounted for less than 0 per cent of cases in the US until May. But the cases saw a surge in June. The Centers for Disease Control and Prevention (CDC) revealed that the variant was estimated to account for up to 14 per cent of cases by late June. In the US, XFG accounted for 0% of cases through March. But it started to increase. In April, it reached 2%. It was 6% in late May, 11% in early June and 14% in late June. The CDC found that high or very high levels of cases are found in states like Alabama, Alaska, California, Delaware, Florida, Hawaii, Kentucky, Louisiana, and Texas. The cases are also rising in other states, including Connecticut, Georgia, Indiana, Maryland, Michigan, Minnesota, Mississippi, Missouri, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Utah, Virginia, Washington, and Wisconsin. Another starin, called NB.1.8.1 or Nimbus, is also a common variant in the US, as per the CDC. This variant leads to an extreme sore throat. What Do We Know About The XFG Variant According to the World Health Organization (WHO), XFG is a variant that is a recombinant of the lineages LF.7 and LP.8.1.2. The earliest sample was collected on 27 January 2025. In its June report, the WHO stated that XFG has been designated a variant under monitoring (VUM) with "increasing proportions globally". Experts have said that SARS-CoV-2, the virus that causes COVID-19, is constantly changing. It is accumulating mutations in its genetic code over time; hence, new variants are expected to continue to emerge. Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, told USA TODAY that the variant's mutations may enhance XFG's ability to evade immune responses. However, the world body has evaluated the additional public health risk posed by XFG as low at the global level, considering the available evidence. "There is currently no clear evidence that XFG causes more severe disease or significantly different symptoms than earlier Omicron variants," Verma said. "Importantly, there are no immediate public health concerns associated with this variant." WHO said that the currently approved COVID-19 vaccines are expected to remain effective against this variant against symptomatic and severe disease. What Are The Symptoms Of XFG? According to the CDC, the following are the common COVID-19 symptoms:
